Researchers Liu and colleagues have demonstrated the oncogenic function of PKMYT1 in HCC, highlighting that the overexpression of PKMYT1 in HCC tumor samples stimulates cell growth and mobility by triggering the β-catenin/TCF signaling pathway (Liu et al., 2017). This evidence concerns the gene HNF4A and hepatocellular carcinoma.